ADVERTISEMENT
Use of Fertility Preservation and Assisted Reproductive Technologies to Attempt Pregnancy Among Patients With Breast Cancer
Featuring Hatem Azim, MD, PhD
Hatem Azim, MD, PhD, Monterrey Institute of Technology, Nuevo León, Mexico discussed results from the POSITIVE trial which found that young age was the main factor associated with shorter time to pregnancy among patients with hormone receptor-positive breast cancer.
These results were first reported at the 2023 San Antonio Breast Cancer Symposium.
Source:
Azim H, Niman S, Partridge A, et al. Fertility preservation and assisted reproductive technologies (ART) in breast cancer (BC) patients (pts) interrupting endocrine therapy (ET) to attempt pregnancy. Presented at the 2023 San Antonio Breast Cancer Symposium; December 5-9; San Antonio, Texas. Abstract GS02-11
© 2023 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Oncology Learning Network or HMP Global, their employees, and affiliates.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Visit the OLN Excellence Forums
Advertisement
Advertisement
Advertisement